Show Entire Article
Following are movers you might have missed.
Find out what’s going up, what’s going down and whether our traders would double down, fade or run in the other direction!Peets
The catalyst: Janney analysts said Peet's sales and volume trends continued to deteriorate.
The trade: I’m a fan and think the decline is an opportunity, says Steve Cortes. As a commodity, coffee prices have been cut in half. Around $60 I’m a buyer of Peet's.
-------------------Celgene The catalyst: Celgene said it withdrew an application to market Revlimid in the European Union for newly diagnosed cases of the bone-marrow cancer.The trade: I think it’s interesting down this much, says Stephanie Link, director of research at TheStreet. They still have a good pipeline.
-------------------
Homebuilders ETFThe catalyst: The National Association of Realtors said on Thursday that existing home sales slipped 1.5 percent to an annual rate of 4.55 million units last month. That was in line with analysts' expectations.The trade: I’d stay away. The space has had quite a run already, says Brian Kelly, founder of Shelter Harbor Capital.
-------------------
Gold Miners ETF
Page 1 of 4 | Next PageShow Entire Article
GDX News & Analysis
DATA IS REAL-TIME EXCEPT NOTED WITH *
* DATA DELAYED AT LEAST 15 MINUTES